XTL Biopharmaceuticals Ltd. (TASE:XTLB) Financings
Financings
| Raise | Date |
|---|---|
| Private placement Announced: up to US$2M Use of proceeds: Together with the NeuroNOS acquisition, to remedy the Nasdaq minimum stockholders' equity deficiency | Jan 29, 2026 |
| Raise | Date |
|---|---|
| Private placement Announced: up to US$2M Use of proceeds: Together with the NeuroNOS acquisition, to remedy the Nasdaq minimum stockholders' equity deficiency | Jan 29, 2026 |